Absorption Systems Acquires Perry Scientific

Absorption Systems has acquired Perry Scientific, an in-vivo toxicology and pharmacokinetics testing company, located in San Diego, California.

Patrick Dentinger, President and CEO of Absorption Systems, said: “The acquisition of Perry Scientific furthers our mission to efficiently move clients from the early stages of drug discovery testing for ADME and pharmacokinetics through the definitive safety and toxicology testing necessary for new drug and device submissions.”

“By offering a full range of tests, we will be able to design and perform studies that will get clients to the point of submission to the FDA as quickly as possible,” he added.

Andrew Perry, Founder of Perry Scientific, said; “Joining forces with Absorption Systems is a natural step in our growth because our respective businesses are entirely complementary. Now we can offer our customers the convenience and accuracy of having an entire preclinical testing package performed at a single facility—the combined company offers all the services needed to move a new drug from the benchtop to the clinic.”